BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 73 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,018,302 | -47.1% | 1,400,105 | -7.0% | 0.00% | – |
Q2 2023 | $7,602,468 | +431.8% | 1,505,439 | +99.0% | 0.00% | – |
Q1 2023 | $1,429,571 | -20.1% | 756,387 | -23.9% | 0.00% | – |
Q4 2022 | $1,788,785 | -16.3% | 993,769 | -21.3% | 0.00% | – |
Q3 2022 | $2,136,000 | -31.7% | 1,263,517 | -0.7% | 0.00% | – |
Q2 2022 | $3,129,000 | -51.5% | 1,272,112 | -45.4% | 0.00% | – |
Q1 2022 | $6,452,000 | -46.2% | 2,329,164 | +3.6% | 0.00% | – |
Q4 2021 | $11,985,000 | -35.3% | 2,248,467 | +2.6% | 0.00% | -100.0% |
Q3 2021 | $18,533,000 | -29.4% | 2,190,630 | +1.7% | 0.00% | 0.0% |
Q2 2021 | $26,259,000 | -43.9% | 2,154,212 | +11.6% | 0.00% | 0.0% |
Q1 2021 | $46,837,000 | -12.7% | 1,930,585 | +15.4% | 0.00% | -50.0% |
Q4 2020 | $53,624,000 | +61.7% | 1,673,138 | +52.5% | 0.00% | +100.0% |
Q3 2020 | $33,172,000 | +4.6% | 1,097,320 | +45.8% | 0.00% | 0.0% |
Q2 2020 | $31,720,000 | +123.9% | 752,368 | +32.5% | 0.00% | 0.0% |
Q1 2020 | $14,164,000 | – | 567,688 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 3,449,845 | $110,568,000 | 2.92% |
Boxer Capital, LLC | 2,014,858 | $64,576,000 | 2.08% |
RA Capital Management | 2,589,904 | $83,006,000 | 1.16% |
Artal Group S.A. | 1,646,517 | $52,771,000 | 1.13% |
Burrage Capital Management LLC | 34,891 | $1,118,000 | 0.85% |
Bellevue Group AG | 1,403,000 | $44,967,000 | 0.52% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,511 | $25,720,000 | 0.51% |
Ikarian Capital, LLC | 293,941 | $9,421,000 | 0.42% |
Avoro Capital Advisors LLC | 640,000 | $20,512,000 | 0.35% |
Logos Global Management LP | 123,465 | $3,957,000 | 0.34% |